SavedAdd your journal

Journals / Ege Tıp Dergisi / 2003 / Cilt: 42 - Sayı: 1

Anti-dsDNA levels in the follow up period of lupus nephritis in childhood

Çocukluk çağı lupus nefriti izleminde anti-dsDNA düzeyi

Sevgi MİR
Ahmet KESKİNOĞLU
Pages
19–24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, anti-dsDNA level is an early and a good index of active lupus nephritis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lupus is a chronic inflammatory disease, and characterized by the body's production of antibodies to nuclear components of the cell.
📊
Key Findings & Data:In the study, anti-dsDNA levels and other acute phase reactans are evaluated in activity of five LN patients (mean age 14.0±0.7 years).
💡
Conclusion & Impact:In conclusion, anti-dsDNA level is an early and a good index of active lupus nephritis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Akut faz reaksiyonu · Çocuk · Enzim bağlı immünosorbent tayini

Abstract

Lupus is a chronic inflammatory disease, and characterized by the body's production of antibodies to nuclear components of the cell. It is know that Anti-dsDNA are of primary importance for diagnosis lupus nephritis (LN), appear to play a central role in the pathogenesis of tissue injury. In the study, anti-dsDNA levels and other acute phase reactans are evaluated in activity of five LN patients (mean age 14.0±0.7 years). The patients were classified according to begining of the clinical findings and renal biopsy (WHO classification criteria). Disease activity were evaluated with acute phase reactants; which were high ESR, lower C3 levels, positive ANA and compared with anti-dsDNA levels. The patients were treated with prednisone, chlorochine or cyclophosphamide according to the classification criteria. In the following period (7.0±0.7 years), there were 5 activity attacks in 4 patients. The levels of anti-dsDNA were elevated in early phase of activated LN and correlated with disease activity. In conclusion, anti-dsDNA level is an early and a good index of active lupus nephritis.

Özet

Lupus hücrenin nükleer elemalarına karşı antikor üretimi ile karekterli kronik inflamatuvar bir hastalıktır. Doku hasarı patogenezlnde yer alan Anti-dsDNA lupus nefriti (LN) tanı ve izleminde önemli bir yere sahiptir. Çalışmada Akut faz reaktanları ve anti-dsDNA düzeyleri 5 LNTi hastanın (yaş ort.14.0±0.7 yıl) akut ataklarını değerledirmek için kullanıldı. Hastalar başlangıç klinik ve böbrek biyopsi bulgularına göre sınıflandırıld. Hastalığın aktivitivetisi akut faz reaktanları He değerledirildi (yüksek ESH, düşük C3 ve pozitif ANA) ve anti-dsDNA düzeyi He karşılaştırıldı. Hastalar sınıflamalarına göre prednisolon, kolşisin veya siklofosfamid He tedavi edildi, /z/em süresince (7.0±0.7yıl) 4 hastada 5 atak gözlendi. Anti-dsDNA düzeyleri atağın erken fazında ilk artan gösterge oldu. Sonuç olarak anti-dsDNA düzeyi lupus aktivitesii değerlendirmek için erken ve iyi bir göstergedir.

🔖

Cite This Article

MİR, S., KESKİNOĞLU, A. (2003). Anti-dsDNA levels in the follow up period of lupus nephritis in childhood. Ege Tıp Dergisi, Cilt: 42 - Sayı: 1, 19–24. https://ajindex.com/articles/223346

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Lehman TJA, Mouradian JA. Systemic lupus erythematosus. In: Barrat TM, Avner ED, Harmon WE, eds. Pediatric Nephrology, 4th ed. Baltimore:Williams & Wilkins, 1999, 793 – 822
  2. Iqbal S,Sher MR, Good RA, Cawkwell GD. Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 1999;135: 500-5
  3. Gedalia A, Molina JF, Molina J,Uribe O, Malagon C, Espinoza LR. Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans. J Natl Med Assoc 1999;9:497-501
  4. Esdaile JM, Abrahamowicz M, Joseph L, et al. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus: why some tests fail. Arthritis Rheum 1996;39(3):370-8
  5. Pisetsky DS. Anti-DNA antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:437-54
  6. Oksel F.Sistemik Lupus Eritematoz. Klinik romatoloji (Eds: Gümüşdiş G, Doğanavşargil E) Ege Romatoloji. 287-302, 1999
  7. Bootsma H, Spronk P, Derksen R, et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995;345(8965):1595-9 [Erratum, Lancet 1995;346 (8973):516] 8. Niaudet P. Treatment of lupus nephritis in children. Pediatr Nephrol 2000;14:158–166
  8. P.Horak et al. Clinical Utility of Selected Disease Activity Markers in Patients with Systemic Lupus Erythematosus Clin Rheumatol (2001) 20:337.344
  9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7
  10. Cassidy JT, Petty RE. Textbook of Pediatric Rheumatology. 3th ed. WB Saunders Company. Philadelphia London, Toronto, Monteral, Sydney, Tokyo. 1995 pp. 260-322
  11. Ruiz-Irastorza G, Guillermo R, Khamastha MA, Castellino GH, Graham RV. Systemic lupus erythematosus. Lancet. 2001; 357:1027
  12. Yu CL, Sun KH, C. Tsai CY, Hsieh SC, Yu HS. Anti-dsDNA antibody up-regulates interleukin 6, but not cyclo-oxygenase gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage? Inflamm. res. 2001; 50:12–18
  13. T. Witte K. Hartung T. Matthias C. Sachse, M. Fricke H. Deicher J. R. Kalden H. J. Lakomek H. H. Peter R. E. Schmidt. Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. Rheumatol Int. 1998;18: 63–69.